Cholesgen
Latest round
- Series A
Last raised
- Feb 2025
Total raised
- $14M
Investors
- 6
About Cholesgen
Established in 2021 and based in Shanghai, China, Cholesgen operates as a biopharmaceutical company that focuses on the research and development of cardiovascular and metabolic drugs. Cholesgen developed R&D platforms, including biochemistry and cell biology platform, animal models of disease, structural biology, medicinal chemistry and human genetics. Based on biochemistry, disease biology, medicinal chemistry and clinical translational medicine, the company provides innovative drugs for metabolic diseases (hyperlipidemia, obesity, diabetes, atherosclerosis and NASH) and tumors. Its platforms and products are mainly used in the medical field. The company generates revenue by providing source innovative drugs for metabolic diseases and tumors. The company will use the funds to promote multiple core pipelines into clinical application and development, as well as the expansion of R&D platforms and teams.
Who invested in Cholesgen
6 investors across 3 rounds
See all investors in Cholesgen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cholesgen
Who invested in Cholesgen?
Cholesgen has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cholesgen raised?
Cholesgen has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cholesgen last raise money?
Cholesgen's most recent round on record is a Series A, in Feb 2025.
What does Cholesgen do?
Established in 2021 and based in Shanghai, China, Cholesgen operates as a biopharmaceutical company that focuses on the research and development of cardiovascular and metabolic drugs.
Where is Cholesgen headquartered?
Cholesgen is headquartered in Shanghai, China.
Which VCs invest in companies like Cholesgen?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Cholesgen's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Cholesgen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.